Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,351–22,375 of 27,380 studies, newest first · page 895 of 1096.

November 2007 25

  1. 2007-11-15
  2. 2007-11-14

    Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of neurochemistry

    Key finding: Most individuals with Down Syndrome (DS) show an early-onset of Alzheimer's disease (AD), which potentially results from the presence of an extra copy of a segment of chromosome 21. +1 more finding

  3. 2007-11-14

    Selective changes of resting-state networks in individuals at risk for Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Only selected areas of the DMN and the executive attention network demonstrated reduced network-related activity in the patient group. +2 more findings

  4. 2007-11-14

    STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier

    ✓ Peer-reviewed Inflammation and the immune system Blood

    Key finding: Our previous works demonstrated that HIV-1 activates pro-inflammatory and interferon-alpha-inducible genes in human brain microvascular endothelial cells (HBMECs) and that these genes are linked to the Janus kinase (JAK)/STAT pathway.

  5. 2007-11-14

    Synaptic proteins, neuropathology and cognitive status in the oldest-old

    ✓ Peer-reviewed Cognitive tests and assessment Neurobiology of aging

    Key finding: However, senile plaque and neurofibrillary tangle pathology do not consistently differentiate individuals with and without dementia. +3 more findings

  6. 2007-11-14

    NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Use of NSAIDs was associated with a lower risk of dementia (adjusted hazard ratio or aHR 0.76, 95% CI or CI 0.60-0.96) and, in particular, AD (aHR 0.63, CI 0.45-0.88), but not VaD (aHR 0.92, CI 0.65-1.28). +2 more findings

  7. 2007-11-12

    Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease

    ✓ Peer-reviewed Genetics Archives of neurology

    Key finding: Unadjusted, SNP RS4420638 within APOC1 was strongly associated with AD due entirely to linkage disequilibrium with APOE. +1 more finding

  8. 2007-11-07

    Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I

    ✓ Peer-reviewed Clinical safety Dementia and geriatric cognitive disorders

    Key finding: This large study has provided additional robust evidence for the existence of neuropsychiatric subsyndromes in AD.

  9. 2007-11-06

    A 93-year-old man with advanced dementia and eating problems

    ✓ Peer-reviewed End-of-life care JAMA

    Key finding: More than 5 million Americans have dementia, a leading cause of death among persons older than 65 years in the United States. +3 more findings

  10. 2007-11-01

    Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMR

    ✓ Peer-reviewed Risk factors Biochemistry

    Key finding: The molecular structure of amylin protofilaments in striated ribbons closely resembles the protofilament in amyloid fibrils with a similar morphology formed by the 40-residue beta-amyloid peptide that is associated with Alzheimer's disease.

  11. 2007-11-01

    Associations of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons

    ✓ Peer-reviewed Digital health tools The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: In very healthy older adults, performance-based measures better predict early cognitive decline than do subjective measures, and tasks requiring greater functional reserve, such as fast-paced walking, appear to be the most sensitive in assessing these relationships. +2 more findings

  12. 2007-11-01

    Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

    ✓ Peer-reviewed Drug development The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Here, we found that activation of GSK-3 by wortmannin or transient overexpression of wild-type GSK-3beta could suppress the induction of long-term potentiation (LTP) in rat hippocampus, whereas simultaneous inhibition of GSK-3 by lithium or SB216763 or transient expression of a dominant-negative GSK-3beta mutant (dnGSK-3beta) preserved the LTP. +3 more findings

  13. 2007-11-01

    Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

    ✓ Peer-reviewed Drug development The Journal of clinical investigation

    Key finding: Recent epidemiological evidence suggests that some antihypertensive medications may reduce the risk for Alzheimer disease (AD). +4 more findings

  14. 2007-11-01

    Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action

    ✓ Peer-reviewed Treatments Chembiochem : a European journal of chemical biology

    Key finding: When the exponential rate is affected exclusively, such as in the case of Congo red and tetracycline, then the inhibitor affinity might be higher for the pleated beta-sheet structure. +4 more findings

  15. 2007-11-01

    Oxidative damage in mild cognitive impairment and early Alzheimer's disease

    ✓ Peer-reviewed Mild cognitive impairment Journal of neuroscience research

    Key finding: Multiple studies show significantly increased levels of lipid peroxidation and protein, DNA, and RNA oxidation in vulnerable regions of the brain of patients with late-stage AD (LAD). +1 more finding

  16. 2007-11-01

    Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

    ✓ Peer-reviewed Mild cognitive impairment NeuroImage

    Key finding: In addition to the hippocampus and the medial temporal lobe gray matter, a number of other regions displayed significant atrophy, including orbitofrontal and medial-prefrontal grey matter, cingulate (mainly posterior), insula, uncus, and temporal lobe white matter. +2 more findings

  17. 2007-11-01

    Cognitive impairment in amyotrophic lateral sclerosis

    ✓ Peer-reviewed Lewy body dementia The Lancet. Neurology

    Key finding: We review studies of cognitive impairment in ALS and common neuropsychological test results.

  18. 2007-11-01

    Semantic dementia: a unique clinicopathological syndrome

    ✓ Peer-reviewed Lewy body dementia The Lancet. Neurology

    Key finding: Semantic dementia (SD), one of the main clinical variants of frontotemporal dementia, presents a unique combination of clinical and imaging abnormalities. +4 more findings

  19. 2007-11-01

    Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease

    ✓ Peer-reviewed Lewy body dementia The Journal of cell biology

    Key finding: Mutations in the ESCRT-III subunit CHMP2B were recently associated with frontotemporal dementia and amyotrophic lateral sclerosis (ALS), neurodegenerative diseases characterized by abnormal ubiquitin-positive protein deposits in affected neurons. +2 more findings

  20. 2007-11-01

    Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy

    ✓ Peer-reviewed Digital health tools Movement disorders : official journal of the Movement Disorder Society

    Key finding: The clinical syndrome of pure akinesia has most often been associated with progressive supranuclear palsy (PSP) and is characterized by difficulty initiating gait and "freezing" during walking, writing and speaking.

  21. 2007-11-01

    Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia

    ✓ Peer-reviewed Brain scans and imaging Archives of neurology

    Key finding: Clinical, neuropsychological, and imaging profiles can contribute to accurate antemortem diagnosis in FTD. +2 more findings

  22. 2007-11-01

    Phase lag index: assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sources

    ✓ Peer-reviewed Brain scans and imaging Human brain mapping

    Key finding: The PLI performed at least as well as the PC in detecting true changes in synchronization in model and real data but, at the same token and like-wise the IC, it was much less affected by the influence of common sources and active reference electrodes. +1 more finding

  23. 2007-11-01

    Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: The amnestic syndrome of the medial temporal type, defined by the Free and Cued Selective Recall Reminding Test, is able to distinguish patients at an early stage of Alzheimer disease from mild cognitive impairment non-converters. +1 more finding

  24. 2007-11-01

    Low vitamin B-12 status and risk of cognitive decline in older adults

    ✓ Peer-reviewed Prevention and risk The American journal of clinical nutrition

    Key finding: Low vitamin B-12 status was associated with more rapid cognitive decline. +4 more findings

  25. 2007-11-01

    Vascular factors predict rate of progression in Alzheimer disease

    ✓ Peer-reviewed Prevention and risk Neurology

    Key finding: Atrial fibrillation, hypertension, and angina were associated with a greater rate of decline and may represent modifiable risk factors for secondary prevention in Alzheimer disease. +2 more findings

Browse the library by subject, with the full score breakdown →